Index RUT P/E 61.96 EPS (ttm) 1.93 Insider Own 3.36% Shs Outstand 34.04M Perf Week 11.15%
Market Cap 4.08B Forward P/E 42.61 EPS next Y 2.81 Insider Trans 0.03% Shs Float 32.94M Perf Month -4.65%
Enterprise Value 4.20B PEG 1.12 EPS next Q 0.36 Inst Own 109.08% Short Float 25.10% Perf Quarter -12.03%
Income 71.66M P/S 7.69 EPS this Y 130.68% Inst Trans -9.80% Short Ratio 7.69 Perf Half Y 73.66%
Sales 531.29M P/B 12.82 EPS next Y 20.69% ROA 8.69% Short Interest 8.27M Perf YTD 92.16%
Book/sh 9.35 P/C 10.20 EPS next 5Y 55.29% ROE 28.21% 52W High 169.29 -29.23% Perf Year -20.88%
Cash/sh 11.75 P/FCF 235.41 EPS past 3/5Y - - ROIC 8.59% 52W Low 55.00 117.84% Perf 3Y 114.91%
Dividend Est. - EV/EBITDA 41.90 Sales past 3/5Y 144.36% 79.64% Gross Margin 59.74% Volatility 4.71% 4.60% Perf 5Y 610.62%
Dividend TTM - EV/Sales 7.91 EPS Y/Y TTM 2410.18% Oper. Margin 14.41% ATR (14) 5.72 Perf 10Y -
Dividend Ex-Date - Quick Ratio 9.17 Sales Y/Y TTM 48.09% Profit Margin 13.49% RSI (14) 56.41 Recom 1.75
Dividend Gr. 3/5Y - - Current Ratio 9.86 EPS Q/Q 165.83% SMA20 5.43% Beta 2.09 Target Price 144.10
Payout 0.00% Debt/Eq 1.63 Sales Q/Q 37.68% SMA50 3.36% Rel Volume 0.72 Prev Close 119.15
Employees 728 LT Debt/Eq 1.62 Earnings Jul 30 AMC SMA200 26.62% Avg Volume 1.08M Price 119.81
IPO May 02, 2019 Option/Short Yes / Yes EPS/Sales Surpr. 104.44% 6.53% Trades
Volume 776,946 Change 0.55%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-16-25 Initiated Evercore ISI
Outperform
$155
Sep-04-25 Initiated Stifel
Hold
$115
Dec-17-24 Downgrade JP Morgan
Overweight → Neutral
$116 → $75
Nov-22-24 Downgrade Needham
Buy → Hold
Oct-29-24 Reiterated Oppenheimer
Outperform
$200 → $125
Oct-29-24 Reiterated Needham
Buy
$208 → $109
Sep-24-24 Initiated Robert W. Baird
Outperform
$200
Aug-21-24 Initiated Needham
Buy
$208
Jun-06-24 Initiated Cantor Fitzgerald
Overweight
$161
Jun-04-24 Initiated Stephens
Overweight
$151
Mar-28-24 Initiated Piper Sandler
Overweight
$95
Jul-19-23 Initiated Robert W. Baird
Outperform
Aug-02-22 Upgrade JP Morgan
Neutral → Overweight
$48
Oct-08-20 Downgrade JP Morgan
Overweight → Neutral
$15
Apr-07-20 Initiated Oppenheimer
Outperform
$25
May-28-19 Initiated Morgan Stanley
Equal-Weight
May-28-19 Initiated JP Morgan
Overweight
May-28-19 Initiated Cowen
Outperform
May-28-19 Initiated Canaccord Genuity
Buy
Show Previous Ratings
Today 09:40AM
Sep-16-25 09:35AM
Sep-10-25 12:59AM
Sep-08-25 04:59PM
Aug-29-25 12:24PM
11:30AM
Loading…
11:30AM
Aug-25-25 04:05PM
11:17AM
Aug-22-25 09:50AM
Aug-21-25 02:03PM
(Investor's Business Daily)
Aug-20-25 09:45AM
Aug-14-25 08:35AM
Aug-13-25 02:16PM
Aug-12-25 09:30AM
Aug-06-25 09:50AM
12:58PM
Loading…
Aug-05-25 12:58PM
(Investor's Business Daily)
Aug-04-25 09:45AM
08:00AM
Aug-02-25 03:21PM
Aug-01-25 04:05PM
12:07PM
Jul-31-25 01:16PM
03:33AM
Jul-30-25 07:00PM
06:05PM
05:06PM
05:04PM
(Associated Press Finance)
04:05PM
Jul-29-25 04:05PM
09:35AM
08:33AM
Loading…
08:33AM
12:00AM
Jul-28-25 08:03AM
Jul-23-25 04:17PM
Jul-16-25 04:05PM
Jul-15-25 10:03AM
Jul-03-25 07:00PM
Jun-30-25 04:21AM
Jun-28-25 09:10AM
Jun-26-25 08:23AM
Jun-24-25 03:09PM
Jun-12-25 07:53AM
Jun-09-25 09:36AM
07:29AM
Jun-05-25 10:02AM
Jun-02-25 09:55AM
May-27-25 04:05PM
May-23-25 10:36AM
May-20-25 04:05PM
May-15-25 12:20PM
12:00PM
May-14-25 04:51AM
May-13-25 11:13AM
05:18AM
03:11AM
May-10-25 01:20PM
May-09-25 04:03PM
(Yahoo Finance Video) +19.64%
+6.48%
12:42PM
12:03PM
10:06AM
(Investor's Business Daily)
03:41AM
May-08-25 07:00PM
05:50PM
04:49PM
(Associated Press Finance)
04:05PM
May-07-25 05:20PM
09:55AM
May-06-25 12:50PM
May-05-25 09:15AM
Apr-28-25 09:50AM
Apr-26-25 06:45AM
Apr-25-25 09:45AM
Apr-24-25 04:05PM
07:45AM
Apr-23-25 04:23AM
Apr-22-25 06:53AM
Apr-14-25 08:38AM
08:04AM
Apr-12-25 08:01AM
Apr-11-25 05:45AM
Apr-10-25 09:21AM
Apr-08-25 01:19PM
09:20AM
05:45AM
Apr-06-25 03:29PM
Apr-04-25 02:30PM
01:43PM
10:42AM
05:45AM
Apr-03-25 09:45AM
Apr-02-25 04:05PM
09:30AM
08:10AM
12:01AM
Apr-01-25 10:01AM
05:45AM
Mar-31-25 06:51PM
11:36AM
04:39AM
Mar-28-25 01:39PM
TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Hassanein Waleed H President & CEO Aug 06 '25 Buy 118.68 8,400 996,912 477,759 Aug 08 04:30 PM Hassanein Waleed H President & CEO Aug 07 '25 Buy 116.25 8,475 985,209 486,234 Aug 08 04:30 PM Basile Edward M Director Aug 04 '25 Option Exercise 0.70 4,143 2,900 7,009 Aug 05 04:30 PM Basile Edward M Director Aug 04 '25 Sale 125.51 4,143 519,988 2,866 Aug 05 04:30 PM EDWARD BASILE Director Aug 04 '25 Proposed Sale 125.51 4,143 519,988 Aug 04 04:06 PM Ranganath Anil P. See remarks Jun 09 '25 Sale 139.80 686 95,903 13,955 Jun 10 04:44 PM Basile Edward M Director May 27 '25 Option Exercise 0.70 5,000 3,500 7,866 May 29 04:30 PM Basile Edward M Director May 27 '25 Sale 126.45 5,000 632,250 2,866 May 29 04:30 PM EDWARD BASILE Director May 27 '25 Proposed Sale 126.45 5,000 632,250 May 27 04:18 PM Weill David Director May 23 '25 Sale 123.88 732 90,680 12,134 May 23 06:41 PM DAVID WEILL Director May 23 '25 Proposed Sale 123.88 732 90,683 May 23 05:26 PM Basile Edward M Director May 09 '25 Option Exercise 0.70 6,000 4,200 6,732 May 13 05:43 PM Basile Edward M Director May 09 '25 Sale 115.63 6,000 693,780 732 May 13 05:43 PM EDWARD BASILE Director May 09 '25 Proposed Sale 115.63 6,000 693,780 May 09 04:02 PM Khayal Tamer I Chief Commercial Officer Mar 03 '25 Sale 76.43 2,407 183,967 36,042 Mar 05 04:30 PM Gordon Stephen Officer Mar 04 '25 Proposed Sale 65.61 5,942 389,855 Mar 04 11:33 AM Khayal Tamer I Chief Commercial Officer Jan 07 '25 Option Exercise 13.28 1,083 14,382 21,926 Jan 10 04:29 PM Khayal Tamer I Chief Commercial Officer Jan 07 '25 Sale 80.05 1,083 86,694 20,843 Jan 10 04:29 PM Khayal Tamer I Chief Commercial Officer Dec 02 '24 Option Exercise 13.28 1,084 14,396 21,927 Dec 04 06:00 PM Khayal Tamer I Chief Commercial Officer Dec 02 '24 Sale 86.40 1,084 93,658 20,843 Dec 04 06:00 PM Khayal Tamer I Chief Commercial Officer Nov 11 '24 Option Exercise 38.46 1,458 56,075 22,301 Nov 13 04:30 PM Khayal Tamer I Chief Commercial Officer Nov 11 '24 Sale 90.04 1,458 131,278 20,843 Nov 13 04:30 PM Basile Edward M Director Nov 05 '24 Option Exercise 28.12 6,750 189,810 7,482 Nov 07 04:30 PM Basile Edward M Director Nov 05 '24 Sale 83.55 6,750 563,994 732 Nov 07 04:30 PM Khayal Tamer I Chief Commercial Officer Nov 01 '24 Option Exercise 13.28 1,083 14,382 21,926 Nov 05 04:30 PM Khayal Tamer I Chief Commercial Officer Nov 01 '24 Sale 82.64 1,083 89,499 20,843 Nov 05 04:30 PM EDWARD BASILE Director Nov 05 '24 Proposed Sale 83.56 6,750 564,008 Nov 05 04:10 PM Tamer Khayal Officer Nov 01 '24 Proposed Sale 81.97 7,625 625,021 Nov 01 04:09 PM Hassanein Waleed H President & CEO Oct 15 '24 Option Exercise 13.28 8,625 114,540 70,268 Oct 17 04:30 PM Hassanein Waleed H President & CEO Oct 15 '24 Sale 132.71 8,625 1,144,648 61,643 Oct 17 04:30 PM Khayal Tamer I Chief Commercial Officer Oct 01 '24 Option Exercise 33.14 2,958 98,021 23,801 Oct 03 04:30 PM Khayal Tamer I Chief Commercial Officer Oct 01 '24 Sale 148.24 2,958 438,491 20,843 Oct 03 04:30 PM
